Literature DB >> 10631318

Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines.

T Mori1, H Okamoto, N Takahashi, R Ueda, T Okamoto.   

Abstract

The p53-binding protein 2 (53BP2) was identified as a binding protein to a tumor suppressor p53. We examined the genetic aberrations of 53BP2 gene in various human cancer cell lines. Although no gross genomic alteration or mutation of 53BP2 gene was observed, 53BP2 mRNA levels were highly variable. There was no association between the 53BP2 mRNA level and the p53 status. When we examined sensitivities of these cell lines to DNA-damaging agents including UV irradiation, X-ray irradiation and cis-diamine-dichloroplatinum (CDDP), we found that higher 53BP2 mRNA expression was correlated with the sensitivity to these agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631318     DOI: 10.1016/s0014-5793(99)01726-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells.

Authors:  Guilin Li; Renzhi Wang; Jun Gao; Kan Deng; Junji Wei; Yanping Wei
Journal:  Mol Cell Biochem       Date:  2010-12-24       Impact factor: 3.396

3.  Flexible Tethering of ASPP Proteins Facilitates PP-1c Catalysis.

Authors:  Yeyun Zhou; Robyn Millott; Hyeong Jin Kim; Shiyun Peng; Ross A Edwards; Tamara Skene-Arnold; Michal Hammel; Susan P Lees-Miller; John A Tainer; Charles F B Holmes; J N Mark Glover
Journal:  Structure       Date:  2019-08-08       Impact factor: 5.006

Review 4.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

5.  Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.

Authors:  Kerstin M Kampa; Jared D Acoba; Dexi Chen; Joel Gay; Hunjoo Lee; Kelly Beemer; Emerson Padiernos; Nataya Boonmark; Zhiyi Zhu; Alice C Fan; Alexis S Bailey; William H Fleming; Christopher Corless; Dean W Felsher; Louie Naumovski; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

Review 6.  ASPP: a new family of oncogenes and tumour suppressor genes.

Authors:  A Sullivan; X Lu
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

7.  ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.

Authors:  Ying Shi; Yue Han; Fang Xie; Anna Wang; Xiaokun Feng; Ning Li; Hongliang Guo; Dexi Chen
Journal:  J Cell Mol Med       Date:  2014-12-23       Impact factor: 5.310

8.  Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.

Authors:  Darrell C Bessette; Erik Tilch; Tatjana Seidens; Michael C J Quinn; Adrian P Wiegmans; Wei Shi; Sibylle Cocciardi; Amy McCart-Reed; Jodi M Saunus; Peter T Simpson; Sean M Grimmond; Sunil R Lakhani; Kum Kum Khanna; Nic Waddell; Fares Al-Ejeh; Georgia Chenevix-Trench
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

9.  Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation.

Authors:  Bin Song; Qi Bian; Yi-Jie Zhang; Cheng-Hao Shao; Gang Li; An-An Liu; Wei Jing; Rui Liu; Ying-Qi Zhou; Gang Jin; Xian-Gui Hu
Journal:  Mol Cancer       Date:  2015-10-05       Impact factor: 27.401

10.  Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.

Authors:  Xiuhong Liu; Shuang Wang; Xianghua Guo; Feili Wei; Jiming Yin; Yunjin Zang; Ning Li; Dexi Chen
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.